IPP Bureau
CK Birla doctors perform rare laparoscopic surgery on seven-year-old for chronic pancreatitis
By IPP Bureau - May 18, 2022
Surgical treatment of chronic pancreatitis is challenging in children and especially laparoscopic surgery has been rarely reported, worldwide
Sun Pharma to launch Brillo, a first-in-class oral lipid-lowering drug in India
By IPP Bureau - May 18, 2022
Bempedoic Acid administered as a 180-mg dose, is approved by the USFDA and European Union for the treatment of hypercholesterolemia
Themis Medicare gets add on approval for Viralex
By IPP Bureau - May 18, 2022
Viralex (Inosine Pranobex) is an immunomodulatory agent with broad-spectrum antiviral properties
Eight Roads announce US $ 250 million healthcare fund for India
By IPP Bureau - May 17, 2022
This new fund is amongst the largest for the sector in India
Covestro to showcase material solutions from wound care to wearable smart patches
By IPP Bureau - May 17, 2022
Wearable patch sensors (smart patches) are rising in popularity, as they offer a wide range of options for medical diagnosis
BDR Pharma receives Rs. 685 crore of PE investment
By IPP Bureau - May 17, 2022
Multiples is the first private equity (PE) investor in the company
RadNet’s AI subsidiaries obtain USFDA clearance for mammography and prostrate AI tools
By IPP Bureau - May 17, 2022
Quantib Prostate is an AI-based software solution that advances the MRI prostate reporting workflow and is accessible directly from the radiologist's reading station
BenevolentAI achieves third milestone in its AI-enabled drug discovery collaboration with AstraZeneca
By IPP Bureau - May 17, 2022
A total of three targets have been selected for portfolio entry in the collaboration to date, with the potential to generate further future development milestones and sales-based royalty revenues for BenevolentAI
Sahajanand Medical Technologies win award for Supraflex Cruz
By IPP Bureau - May 17, 2022
Union Minister of State for Science and Technology, Dr Jitendra Singh gave the award for the successful commercialization of indigenous technology on National Technology Day 2022
Aster DM Healthcare partners with Skye Air Mobility for drone delivery
By IPP Bureau - May 17, 2022
Following the successful completion of the 7day BVLOS trials, Skye Air targets to undertake approximately 80 flights, each carrying blood samples and medicines for Aster Clinics
Moderna announces advancements in mRNA platform science for application across multiple diseases
By IPP Bureau - May 17, 2022
Moderna continues to expand its mRNA platform for a range of additional clinical applications and routes of administration including a modality for lung delivery
University of Nebraska Medical Center and ANANDA Scientific announce USFDA approval
By IPP Bureau - May 17, 2022
The study will evaluate the effectiveness of Nantheia ATL5, an investigational drug using cannabidiol in ANANDA’s proprietary delivery technology
Adroit BioMed launches Fortisil range of skincare products
By IPP Bureau - May 17, 2022
Boehringer Ingelheim’s treatment slowed lung function decline in people living with idiopathic pulmonary fibrosis
By IPP Bureau - May 16, 2022
Potential new treatment for progressive pulmonary fibrosis (PPF) builds on Boehringer Ingelheim’s leadership in lung fibrosis and will be further investigated in a phase III clinical trial program
Antengene announces commercial availability of Xpovio in China
By IPP Bureau - May 16, 2022
The drug will be available in 600 hospitals and 105 DTPs
